- Ongoing, recruitingTherapeutic exploratory (Phase II)
Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial.- The CARAMEL Study
This study, called CARAMEL, is looking at whether a cannabis-related medicine (CBD) can help people reduce their drinking when they have alcohol use disorder. It also checks if CBD can affect how alcohol impacts the brain and liver. It's a key step in understanding new ways to help.
For: Psychiatric disordersFrance - AuthorisedTherapeutic exploratory (Phase II)
Efficacy and safety of cannabidiol for pain relief of patients with end-stage metastatic castration resistant prostate cancer - a randomised double-blinded placebo-controlled phase II trial (ProCan)
This study is looking at whether a cannabis-based medicine called cannabidiol (CBD) can help men with advanced prostate cancer manage their pain and possibly reduce their need for strong painkillers. We want to see if CBD is safe and effective compared to a dummy treatment.
For: Prostate cancerDenmark - AuthorisedTherapeutic confirmatory (Phase III)
IMpAct of CardiolRxTM oVer 6 months following IL-1 Blocker cessation in pERICarditis patients – MAVERIC: A randomized, double-blind, placebo-controlled trial
This study is testing a new medicine, CardiolRx, for people who have recurring episodes of pericarditis, which is swelling around the heart. It wants to see if CardiolRx can help prevent these episodes after stopping another treatment called an IL-1 blocker.
For: Recurrent PericarditisGreece · Italy